Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors
出版年份 2023 全文链接
标题
Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors
作者
关键词
-
出版物
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume -, Issue -, Pages 108631
出版商
Elsevier BV
发表日期
2023-10-18
DOI
10.1016/j.jdiacomp.2023.108631
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SGLT2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes
- (2023) Tejas Patel ANNALS OF INTERNAL MEDICINE
- Sequential and Dynamic Variations of IL-6, CD18, ICAM, TNF-α, and Microstructure in the Early Stage of Diabetic Retinopathy
- (2022) Ang Xiao et al. DISEASE MARKERS
- Kidney and heart failure outcomes associated with SGLT2 inhibitor use
- (2022) Annemarie B. van der Aart-van der Beek et al. Nature Reviews Nephrology
- Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment
- (2022) Samraa H. Abdel-Kawi et al. Stem Cells International
- NF-κB: blending metabolism, immunity, and inflammation
- (2022) Daria Capece et al. TRENDS IN IMMUNOLOGY
- Capsaicin ameliorates diabetic retinopathy by inhibiting poldip2-induced oxidative stress
- (2022) Kou Liu et al. Redox Biology
- The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications
- (2022) Tong Yue et al. Frontiers in Immunology
- Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function
- (2022) Wan Zhou et al. Frontiers in Endocrinology
- H3 Relaxin Alleviates Migration, Apoptosis and Pyroptosis Through P2X7R-Mediated Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation in Retinopathy Induced by Hyperglycemia
- (2021) Kelaier Yang et al. Frontiers in Pharmacology
- Progress of Nanotechnology in Diabetic Retinopathy Treatment
- (2021) Yuxin Liu et al. International Journal of Nanomedicine
- Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats
- (2021) Krit Jaikumkao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis
- (2021) Shimaa K. Elkazzaz et al. LIFE SCIENCES
- Sodium‐glucose co‐transporter 2 inhibitors on weight change and cardiometabolic profiles in individuals with overweight or obesity and without diabetes: A meta‐analysis
- (2021) John Wong et al. Obesity Reviews
- Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes
- (2021) Milton Packer JACC-Heart Failure
- Continuous subcutaneous insulin infusion ameliorates bone structures and mechanical properties in type 2 diabetic rats by regulating bone remodeling
- (2021) Peipei Shi et al. BONE
- SGLT-2 inhibitors as cardio-renal protective agents
- (2021) Irene Caruso et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mechanisms Leading to Differential Hypoxia Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
- (2020) Milton Packer AMERICAN JOURNAL OF KIDNEY DISEASES
- Plant compounds for the treatment of diabetes, a metabolic disorder: NF-κB as therapeutic target.
- (2020) Ravi Sahukari et al. CURRENT PHARMACEUTICAL DESIGN
- Long noncoding RNA MIAT regulates primary human retinal pericyte pyroptosis by modulating miR-342–3p targeting of CASP1 in diabetic retinopathy
- (2020) Xinyang Yu et al. EXPERIMENTAL EYE RESEARCH
- A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model
- (2020) Finny Monickaraj et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
- (2020) Karanvir S. Raman et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes
- (2018) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial
- (2017) Kanako Kato et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome
- (2016) Yara A. Samra et al. LIFE SCIENCES
- The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
- (2016) Matthias Kern et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
- (2016) Linda A. Gallo et al. Scientific Reports
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Diabetic Retinopathy: Vascular and Inflammatory Disease
- (2015) F. Semeraro et al. Journal of Diabetes Research
- Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
- (2014) J. Dziuba et al. DIABETES OBESITY & METABOLISM
- Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
- (2013) Sreeneeranj Kasichayanula et al. CLINICAL PHARMACOKINETICS
- Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis
- (2013) Shun-Min Yang et al. DIABETOLOGIA
- Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation: Putative mechanism for aggravating vascular disease in diabetes
- (2010) R. J. Wright et al. DIABETES CARE
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans
- (2009) M. Obermeier et al. DRUG METABOLISM AND DISPOSITION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now